Economic evaluation of the GENESIS-SEFH report of olaratumab with doxorubicin in soft tissue sarcoma in advanced stages
Objective: The economic evaluation of the drug olaratumab is carried out in the treatment of soft tissue sarcoma. Method: The data were analyzed following the recommendations contained in the MADRE program of the GENESIS-SEFH report model. Results: Progression free survival and overall survival r...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Grupo Aula Médica
2018-09-01
|
Series: | Farmacia Hospitalaria |
Subjects: | |
Online Access: | http://www.aulamedica.es/fh/pdf/10917.pdf |